
Novel c-Met ингибитор, markedly reducing tumor growth, showing excellent pharmacodynamics, and suppressing клетка proliferation and microvessel density in an orthotopic model of triple negative breast cancer
Novel c-Met inhibitor, markedly reducing tumor growth, showing excellent pharmacodynamics, and suppressing cell proliferation and microvessel density in an orthotopic model of triple negative breast cancer
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.